139
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of the Effect of Oral Isotretinoin on the Level of Serum YKL40 in Acne Vulgaris Patients: A Cross-Sectional Case-Control

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & show all
Pages 3241-3248 | Received 27 Aug 2023, Accepted 28 Oct 2023, Published online: 08 Nov 2023

References

  • Sharara M, Diab H, Reda AER. A pilot study on serum lactoferrin in patients with mild versus severe acne in correlation with disease duration. J Egypt Women Dermatol Soc. 2019;16(3):193–197. doi:10.4103/JEWD.JEWD_35_19
  • Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):1–29. doi:10.1038/s41598-020-62715-3
  • Greydanus DE, Azmeh R, Cabral MD, Dickson CA, Patel DR. Acne in the first three decades of life: an update of a disorder with profound implications for all decades of life. Dis Month. 2021;67(4):101103. doi:10.1016/j.disamonth.2020.101103
  • Khaled HN, Hamid WGA, Alghobashy Y. Chitinase-3 protein-like-1 as inflammatory marker and disturbed lipid-profile risk in acne vulgaris. Menoufia Med J. 2022;35(2):477. doi:10.4103/mmj.mmj_271_21
  • Patnaik S, Purohit D, Biswasroy P, Diab WM, Dubey A. Recent advances for commedonal acne treatment by employing lipid nanocarriers topically. Int J Health Sci. 2022;6:180–205. doi:10.53730/ijhs.v6nS8.9671
  • Stamu‐O’Brien C, Jafferany M, Carniciu S, Abdelmaksoud A. Psychodermatology of acne: psychological aspects and effects of acne vulgaris. J Cosmet Dermatol. 2021;20(4):1080–1083. doi:10.1111/jocd.13765
  • Becker M, Wild T, Zouboulis CC. Objective assessment of acne. Clin Dermatol. 2017;35(2):147–155. doi:10.1016/j.clindermatol.2016.10.006
  • Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. Acne treatment review and future perspectives. Dermatol Ther. 2022;35(9):e15719. PMID: 35841269. doi:10.1111/dth.15719
  • Fallah H, Rademaker M. Isotretinoin in the management of acne vulgaris: practical prescribing. Int J Dermatol. 2021;60(4):451–460. doi:10.1111/ijd.15089
  • Bussink AP, Speijer D, Aerts JM, Boot RG. Evolution of mamma- lian chitinase(-like) members of family 18 glycosyl hydro- lases. Genetics. 2007;177(2):959–997. doi:10.1534/genetics.107.075846
  • Lee CG, Da Silva CA, la Cruz CS. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73(1):479–501. doi:10.1146/annurev-physiol-012110-142250
  • Ebrahim A, Mustafa AI, El‐Shimi OS, Fathy MA. Serum YKL40: a novel potential link between inflammation and dyslipidemia in Acne Vulgaris. J Cosmet Dermatol. 2020;19(5):1219–1223. doi:10.1111/jocd.13124
  • Kutlu Ö. Effect of isotretinoin treatment on the inflammatory markers in patients with Acne Vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment? Cutan Ocul Toxicol. 2019;39(1):67–70. doi:10.1080/15569527.2019.1701485
  • AlJasser RN, Alaqeely RS, Al-Hoqail IA, et al. Association between isotretinoin use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels. Front Biosci. 2021;26(7):191–197.
  • Metin N, Turan C. The correlation of monocyte to high-density lipoprotein ratio with uric acid and possible atherosclerotic pathway in patients treated with isotretinoin. Authorea Preprints; 2020.
  • Hedetoft M, Hansen MB, Madsen MB, Johansen JS, Hyldegaard O. Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection. BMC Infect Dis. 2021;21(1):1–9. doi:10.1186/s12879-021-06760-x
  • Khashaba SA, Attwa E, Said N, Ahmed S, Khattab F. Serum YKL 40 and IL 17 in Psoriasis: reliability as prognostic markers for disease severity and responsiveness to treatment. Dermatol Ther. 2021;34(1):e14606. doi:10.1111/dth.14606
  • Agamia NF, Aly EA, El-Hadidy A, El-Abd AM, Gaber D. YKL-40, fetuin-A plasma levels, and carotid intima-media thickness: do they have relations with subclinical atherosclerosis associated with psoriasis and the disease severity? J Egypt Women’s Dermatol Soc. 2019;16(2):133. doi:10.4103/JEWD.JEWD_23_19